These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 33948589)

  • 1. Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.
    Rathnasinghe R; Salvatore M; Zheng H; Jangra S; Kehrer T; Mena I; Schotsaert M; Muster T; Palese P; García-Sastre A
    bioRxiv; 2021 Apr; ():. PubMed ID: 33948589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Protection Against Respiratory Viruses Conferred by a Prototype Live Attenuated Influenza Virus Vaccine.
    Rathnasinghe R; Salvatore M; Zheng H; Jangra S; Kehrer T; Mena I; Schotsaert M; Muster T; Palese P; García-Sastre A
    Res Sq; 2021 Aug; ():. PubMed ID: 34401874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1.
    Rathnasinghe R; Salvatore M; Zheng H; Jangra S; Kehrer T; Mena I; Schotsaert M; Muster T; Palese P; García-Sastre A
    Sci Rep; 2021 Nov; 11(1):22164. PubMed ID: 34773048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated influenza virus vaccines with modified NS1 proteins.
    Richt JA; García-Sastre A
    Curr Top Microbiol Immunol; 2009; 333():177-95. PubMed ID: 19768406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine.
    Romanova J; Krenn BM; Wolschek M; Ferko B; Romanovskaja-Romanko E; Morokutti A; Shurygina AP; Nakowitsch S; Ruthsatz T; Kiefmann B; König U; Bergmann M; Sachet M; Balasingam S; Mann A; Oxford J; Slais M; Kiselev O; Muster T; Egorov A
    PLoS One; 2009 Jun; 4(6):e5984. PubMed ID: 19543385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate.
    Wressnigg N; Voss D; Wolff T; Romanova J; Ruthsatz T; Mayerhofer I; Reiter M; Nakowitsch S; Humer J; Morokutti A; Muster T; Egorov A; Kittel C
    Vaccine; 2009 May; 27(21):2851-7. PubMed ID: 19366569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunization with a live attenuated influenza a virus lacking the nonstructural protein 1 induces broad protective immunity in mice.
    Park HJ; Ferko B; Byun YH; Song JH; Han GY; Roethl E; Egorov A; Muster T; Seong B; Kweon MN; Song M; Czerkinsky C; Nguyen HH
    PLoS One; 2012; 7(6):e39921. PubMed ID: 22761928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells.
    Haye K; Burmakina S; Moran T; García-Sastre A; Fernandez-Sesma A
    J Virol; 2009 Jul; 83(13):6849-62. PubMed ID: 19403682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NS1 Protein Mutation I64T Affects Interferon Responses and Virulence of Circulating H3N2 Human Influenza A Viruses.
    DeDiego ML; Nogales A; Lambert-Emo K; Martinez-Sobrido L; Topham DJ
    J Virol; 2016 Nov; 90(21):9693-9711. PubMed ID: 27535054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral Subpopulation Screening Guides in Designing a High Interferon-Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.
    Ghorbani A; Abundo MC; Ji H; Taylor KJM; Ngunjiri JM; Lee CW
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza.
    Steel J; Lowen AC; Pena L; Angel M; Solórzano A; Albrecht R; Perez DR; García-Sastre A; Palese P
    J Virol; 2009 Feb; 83(4):1742-53. PubMed ID: 19073731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication-Defective West Nile Virus with NS1 Deletion as a New Vaccine Platform for Flavivirus.
    Li N; Zhang YN; Deng CL; Shi PY; Yuan ZM; Zhang B
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with live attenuated influenza viruses that express altered NS1 proteins results in potent and protective memory CD8+ T-cell responses.
    Mueller SN; Langley WA; Carnero E; García-Sastre A; Ahmed R
    J Virol; 2010 Feb; 84(4):1847-55. PubMed ID: 19939929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.
    Nogales A; DeDiego ML; Topham DJ; Martínez-Sobrido L
    J Virol; 2016 Jul; 90(14):6291-6302. PubMed ID: 27122587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development.
    Nogales A; Baker SF; Ortiz-Riaño E; Dewhurst S; Topham DJ; Martínez-Sobrido L
    J Virol; 2014 Sep; 88(18):10525-40. PubMed ID: 24965472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1.
    Wacheck V; Egorov A; Groiss F; Pfeiffer A; Fuereder T; Hoeflmayer D; Kundi M; Popow-Kraupp T; Redlberger-Fritz M; Mueller CA; Cinatl J; Michaelis M; Geiler J; Bergmann M; Romanova J; Roethl E; Morokutti A; Wolschek M; Ferko B; Seipelt J; Dick-Gudenus R; Muster T
    J Infect Dis; 2010 Feb; 201(3):354-62. PubMed ID: 20039806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An A14U Substitution in the 3' Noncoding Region of the M Segment of Viral RNA Supports Replication of Influenza Virus with an NS1 Deletion by Modulating Alternative Splicing of M Segment mRNAs.
    Zheng M; Wang P; Song W; Lau SY; Liu S; Huang X; Mok BW; Liu YC; Chen Y; Yuen KY; Chen H
    J Virol; 2015 Oct; 89(20):10273-85. PubMed ID: 26223635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NS1 Protein Amino Acid Changes D189N and V194I Affect Interferon Responses, Thermosensitivity, and Virulence of Circulating H3N2 Human Influenza A Viruses.
    Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28003482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins.
    Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30545063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.